• LAST PRICE
    1.5500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.2000/ 8
  • Ask / Lots
    2.3000/ 1
  • Open / Previous Close
    0.0000 / 1.5500
  • Day Range
    ---
  • 52 Week Range
    Low 1.3000
    High 5.3400
  • Volume
    3
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.62
TimeVolumeFIXX
09:32 ET17831.59
09:37 ET6991.62
09:42 ET2821.62
09:44 ET1001.59
09:48 ET2001.615
09:50 ET1001.6
09:53 ET2001.64
09:55 ET1001.625
10:00 ET2001.6174
10:02 ET14001.59
10:04 ET1001.59
10:06 ET11001.595
10:08 ET3001.58
10:09 ET4001.58
10:11 ET2001.58
10:13 ET1001.58
10:15 ET1001.58
10:18 ET1001.58
10:20 ET1001.59
10:22 ET1001.58
10:24 ET4481.57
10:26 ET3001.55
10:27 ET1001.55
10:29 ET11001.55
10:31 ET1001.55
10:33 ET2001.55
10:36 ET1001.55
10:38 ET2001.56
10:44 ET29001.58
10:45 ET2001.58
10:47 ET1001.58
10:49 ET7021.585
10:51 ET22791.59
10:54 ET11001.56
10:56 ET1001.56
11:00 ET5001.56
11:02 ET2001.56
11:03 ET33011.55
11:05 ET7471.5598
11:07 ET4001.555
11:09 ET49831.555
11:14 ET16001.55
11:16 ET5001.555
11:18 ET4001.55
11:20 ET3001.555
11:23 ET3001.552
11:25 ET92821.55
11:27 ET5001.55
11:30 ET2001.55
11:32 ET2001.55
11:34 ET13001.5599
11:36 ET80351.595
11:38 ET7001.58
11:39 ET1001.58
11:41 ET1001.58
11:43 ET2001.58
11:45 ET1001.58
11:50 ET76001.56
11:52 ET144221.56
11:54 ET22001.575
11:57 ET3001.59
11:59 ET2001.575
12:01 ET1001.575
12:03 ET143531.58
12:06 ET123081.585
12:08 ET2001.585
12:10 ET4001.585
12:15 ET1001.58
12:17 ET91501.57
12:19 ET139001.585
12:21 ET5001.585
12:24 ET4001.585
12:28 ET3001.585
12:30 ET4001.585
12:32 ET7921.5807
12:33 ET1001.58
12:35 ET4001.575
12:37 ET2001.57
12:39 ET5001.56
12:42 ET2001.56
12:44 ET88181.55
12:46 ET12421.53
12:48 ET84041.54
12:50 ET7001.54
12:51 ET9851.53
12:53 ET10001.54
12:55 ET21971.53
12:57 ET7991.54
01:00 ET75811.55
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFIXX
Homology Medicines Inc
89.1M
-16.9x
---
United StatesIKNA
Ikena Oncology Inc
85.6M
-1.6x
---
United StatesSTTK
Shattuck Labs Inc
97.1M
-1.4x
---
United StatesPIRS
Pieris Pharmaceuticals Inc
74.4M
-2.1x
---
United StatesSLGL
Sol Gel Technologies Ltd
111.0M
29.4x
---
United StatesCLSD
Clearside Biomedical Inc
71.0M
-11.7x
---
As of 2022-11-28

Company Information

Homology Medicines, Inc. is a clinical-stage genetic medicines company focused on providing treatment for rare genetic diseases. The Company’s clinical programs include HMI-102, is an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria (PKU); HMI-103, which is an investigational gene editing candidate in clinical development for the treatment of patients with PKU, and HMI-203, which is an investigational gene therapy candidate in clinical development for the treatment of patients with mucopolysaccharidosis type II (MPS II), or Hunter syndrome. Additionally, the Company is developing a gene therapy candidate, HMI-104, from its GTx-mAb platform for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), and conducting research in other diseases, including metachromatic leukodystrophy (MLD). Its platform is designed to utilize human hematopoietic stem cell derived adeno-associated virus vectors.

Contact Information

Headquarters
1 Patriots ParkBEDFORD, MA, United States 01730-2343
Phone
781-301-7277
Fax
302-655-5049

Executives

Chairman of the Board
Arthur Tzianabos
President, Chief Executive Officer, Director
Albert Seymour
Chief Financial Officer, Treasurer, Chief Business Officer
W. Bradford Smith
Chief Commercial Officer
Michael Blum
Chief Legal Officer, Secretary
Paul Alloway

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$89.1M
Revenue (TTM)
$3.2M
Shares Outstanding
57.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.19
EPS
$-0.09
Book Value
$2.97
P/E Ratio
-16.9x
Price/Sales (TTM)
27.8
Price/Cash Flow (TTM)
30.4x
Operating Margin
-36.25%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.